Skip to content
Artwork for JAMA Neurology Author Interviews
Health & FitnessMedicineScience

JAMA Neurology Author Interviews

JAMA Network

Interviews with authors of articles from JAMA Neurology. JAMA Neurology is an international peer-reviewed journal for physicians caring for people with neurologic disorders and those interested in the structure and function of the normal and diseased nervous system.

Play
  • 20 episodes
  • monthly
  • Avg 18 min
  • English
  • September 8 · 19 min

    Smoking, Exhaled Carbon Monoxide, and Risk of Parkinson Disease

    Interview with Prof Zheng-Ming Chen, DPhil author Smoking, Exhaled Carbon Monoxide, and Risk of Parkinson Disease. Hosted by Cynthia E. Armand, MD. Related Content: Smoking, Exhaled Carbon Monoxide, and Risk of Parkinson Disease Exhaled Carbon Monoxide Levels May Offer Clues on the Etiology of Parkinson Disease

  • July 27 · 16 min

    Gefurulimab and Generalized Myasthenia Gravis

    Interview with Kelly G. Gwathmey, MD, author of Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis Gefurulimab—The First Effective Nanobody in Myasthenia Gravis Therapy

  • May 4 · 24 min

    Phenoconversion in Pure Autonomic Failure

    Interview with Alessandra Fanciulli, MD, PhD, and Eduardo de Pablo-Fernández, MD, PhD, authors of Phenoconversion in Pure Autonomic Failure: A Systematic Review and Meta-Analysis. Hosted by Cynthia E. Armand, MD. Related Content: Phenoconversion in Pure Autonomic Failure Pure Autonomic Failure and Central Synucleinopathy Risk

  • April 20 · 22 min

    Brain Biomarkers and a Multidomain Lifestyle Intervention

    Interview with Susan M. Landau, PhD, author of Brain Imaging Biomarkers and Cognitive Outcomes in a Multidomain Lifestyle Intervention: The POINTER Imaging Ancillary Study. Hosted by Cynthia E. Armand, MD. Related Content: Brain Imaging Biomarkers and Cognitive Outcomes in a Multidomain Lifestyle Intervention

  • March 9 · 14 min

    Epstein-Barr Virus Antibodies and Multiple Sclerosis

    Interview with Hannes Vietzen, PhD, author of Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases. Hosted by Cynthia E. Armand, MD. Related Content: Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases

  • Nov 24, 2025 · 23 min

    US Burden of Disorders Affecting the Nervous System

    Interview with John P. Ney, MD, MPH, author of US Burden of Disorders Affecting the Nervous System: From the Global Burden of Disease 2021 Study. Hosted by Cynthia E. Armand, MD. Related Content: US Burden of Disorders Affecting the Nervous System

  • Oct 6, 2025 · 16 min

    Hemorrhage and Risk Factors in Unruptured Brain AVM

    Interview with Helen Kim, PhD, author of Risk of Future Hemorrhage From Unruptured Brain Arteriovenous Malformations: The Multicenter Arteriovenous Malformation Research Study (MARS). Hosted by Cynthia E. Armand, MD. Related Content: Risk of Future Hemorrhage From Unruptured Brain Arteriovenous Malformations

  • Aug 18, 2025 · 19 min

    Intravenous Argatroban or Eptifibatide and Mechanical Thrombectomy

    Interview with Colin P. Derdeyn, MD, author of Intravenous Argatroban or Eptifibatide in Patients Undergoing Mechanical Thrombectomy: A Subgroup Analysis of the MOST Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Intravenous Argatroban or Eptifibatide in Patients Undergoing Mechanical Thrombectomy

  • May 5, 2025 · 21 min

    Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

    Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD. Related Content: Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder

  • Mar 31, 2025 · 16 min

    Optimal Delay Time to Initiate Anticoagulation After AF-Associated Ischemic Stroke

    Interview with Steven J. Warach, MD, PhD, author of Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation

  • Nov 1, 2024 · 22 min

    Alzheimer Disease as a Clinical-Biological Construct

    Interview with Giovanni B. Frisoni, MD, author of Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation. Hosted by Cynthia E. Armand, MD. Related Content: Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation

  • Sep 23, 2024 · 17 min

    Perceived CTE in Former Professional Football Players

    Interview with Rachel Grashow, PhD, MS, and Aaron L. Baggish, MD, authors of Perceived Chronic Traumatic Encephalopathy and Suicidality in Former Professional Football Players. Hosted by Cynthia E. Armand, MD. In the US, you can call, text, or chat 988, the Suicide and Crisis Lifeline. Related Content: Perceived Chronic Traumatic Encephalopathy and Suicidality in Former Professional Football Players

  • Aug 19, 2024 · 15 min

    Localized Nicardipine Release Implants for Prevention of Vasospasm

    Interview with Peter Vajkoczy, MD, author of Localized Nicardipine Release Implants for Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Localized Nicardipine Release Implants for Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage

Showing 1–20 of 20 episodes